Castle Biosciences, Inc. (CSTL)
25.05
+0.49
(+2.00%)
USD |
NASDAQ |
Apr 17, 16:00
25.06
+0.01
(+0.04%)
After-Hours: 20:00
Castle Biosciences Cash from Investing (Quarterly) : 8.831M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.561M |
| Assertio Holdings, Inc. | 1.699M |
| CytoSorbents Corp. | -0.291M |
| Odyssey Health, Inc. | 0.00 |
| Harmony Biosciences Holdings, Inc. | -17.63M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.93M |
| Cash from Financing (Quarterly) | -4.589M |
| Free Cash Flow | 28.33M |
| Free Cash Flow Per Share (Quarterly) | 0.6732 |
| Free Cash Flow to Equity (Quarterly) | 19.87M |
| Free Cash Flow to Firm (Quarterly) | 19.77M |
| Free Cash Flow Yield | 3.88% |